Skip to main content

Cutibacterium acnes periprosthetic joint infections.

Publication ,  Journal Article
Warne, CN; Ryan, S; Yu, E; Osmon, DR; Berry, DJ; Abdel, MP
Published in: Bone Joint J
December 1, 2024

AIMS: Cutibacterium acnes (C. acnes; previously known as Propionibacterium acnes or P. acnes) periprosthetic hip and knee infections are under-reported. While culture contamination with C. acnes occurs, true infections are important to recognize and treat. We sought to describe the demographics and treatment outcomes of patients with C. acnes periprosthetic joint infections (PJIs) of the hip and knee. METHODS: Patients with C. acnes PJI between January 2005 and December 2018 were retrospectively reviewed utilizing the institutional total joint registry. Patients with monomicrobial PJI and two or more positive cultures were considered to have true C. acnes PJI. Patients with polymicrobial infection or with only one positive culture were excluded. This resulted in 35 PJIs (21 hips and 14 knees); the patients' mean age was 63 years (35 to 84) and 15 (43%) were female. Mean follow-up was five years (1 to 14). RESULTS: The median time to positive culture was five days (IQR 5 to 6) and median synovial fluid cell count was 22,583 cells (IQR 15,200 to 53,231). The median ESR was 25 mm/hr (IQR 7 to 37), and CRP was 15 mg/l (IQR 3 to 29). Of the 35 PJIs, 18 (51%) were treated with chronic antibiotic suppression without surgical intervention, and the remainder were treated with two-stage exchange arthroplasty. The two-year survival free of any revision was 94%. Four patients failed treatment due to symptomatic infection, with three treated with two-stage exchange and one treated with irrigation and debridement with modular component exchange for a survival rate of 89% and 83% at two and five years, respectively. CONCLUSION: Laboratory evidence of C. acnes PJI in this cohort was typical compared to more conventional organisms. Cultures grew more quickly than previously thought in patients with C. acnes PJI. Treatment with two-stage exchange or chronic antibiotic suppression alone both had few treatment failures at mid-term follow-up.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Bone Joint J

DOI

EISSN

2049-4408

Publication Date

December 1, 2024

Volume

106-B

Issue

12

Start / End Page

1426 / 1430

Location

England

Related Subject Headings

  • Retrospective Studies
  • Reoperation
  • Prosthesis-Related Infections
  • Propionibacterium acnes
  • Middle Aged
  • Male
  • Knee Prosthesis
  • Humans
  • Hip Prosthesis
  • Gram-Positive Bacterial Infections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Warne, C. N., Ryan, S., Yu, E., Osmon, D. R., Berry, D. J., & Abdel, M. P. (2024). Cutibacterium acnes periprosthetic joint infections. Bone Joint J, 106-B(12), 1426–1430. https://doi.org/10.1302/0301-620X.106B12.BJJ-2024-0437.R1
Warne, Christopher N., Sean Ryan, Elizabeth Yu, Douglas R. Osmon, Daniel J. Berry, and Matthew P. Abdel. “Cutibacterium acnes periprosthetic joint infections.Bone Joint J 106-B, no. 12 (December 1, 2024): 1426–30. https://doi.org/10.1302/0301-620X.106B12.BJJ-2024-0437.R1.
Warne CN, Ryan S, Yu E, Osmon DR, Berry DJ, Abdel MP. Cutibacterium acnes periprosthetic joint infections. Bone Joint J. 2024 Dec 1;106-B(12):1426–30.
Warne, Christopher N., et al. “Cutibacterium acnes periprosthetic joint infections.Bone Joint J, vol. 106-B, no. 12, Dec. 2024, pp. 1426–30. Pubmed, doi:10.1302/0301-620X.106B12.BJJ-2024-0437.R1.
Warne CN, Ryan S, Yu E, Osmon DR, Berry DJ, Abdel MP. Cutibacterium acnes periprosthetic joint infections. Bone Joint J. 2024 Dec 1;106-B(12):1426–1430.

Published In

Bone Joint J

DOI

EISSN

2049-4408

Publication Date

December 1, 2024

Volume

106-B

Issue

12

Start / End Page

1426 / 1430

Location

England

Related Subject Headings

  • Retrospective Studies
  • Reoperation
  • Prosthesis-Related Infections
  • Propionibacterium acnes
  • Middle Aged
  • Male
  • Knee Prosthesis
  • Humans
  • Hip Prosthesis
  • Gram-Positive Bacterial Infections